140 related articles for article (PubMed ID: 7972934)
21. Comparison of the effects of transforming growth factor alpha and epidermal growth factor on gastrointestinal proliferation and hormone release.
Playford RJ; Boulton R; Ghatei MA; Bloom SR; Wright NA; Goodlad RA
Digestion; 1996; 57(5):362-7. PubMed ID: 8886581
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of neurotensin on gastric acid secretion in rats. Development of a bioassay model.
Hammer RA; Hernandez RE; Shepard A
Dig Dis Sci; 1990 Apr; 35(4):439-43. PubMed ID: 2318089
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats.
Karinch AM; Schmidt GL; Kauffman GL
Brain Res; 1998 Nov; 810(1-2):123-9. PubMed ID: 9813278
[TBL] [Abstract][Full Text] [Related]
24. Pituitary adenylate cyclase activating polypeptide-27 (PACAP-27) inhibits pentagastrin-stimulated gastric acid secretion in conscious rats.
Mungan Z; Ozmen V; Ertan A; Arimura A
Regul Pept; 1992 Apr; 38(3):199-206. PubMed ID: 1589595
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury.
Konturek SJ; Brzozowski T; Majka J; Dembinski A; Slomiany A; Slomiany BL
Scand J Gastroenterol; 1992 Aug; 27(8):649-55. PubMed ID: 1439546
[TBL] [Abstract][Full Text] [Related]
26. Increased production of transforming growth factor alpha following acute gastric injury.
Polk WH; Dempsey PJ; Russell WE; Brown PI; Beauchamp RD; Barnard JA; Coffey RJ
Gastroenterology; 1992 May; 102(5):1467-74. PubMed ID: 1568557
[TBL] [Abstract][Full Text] [Related]
27. Gastric mucosal expression and luminal release of growth factors in gastric carcinoma and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek PC; Bielański W; Bobrzyński A; Hahn EG; Konturek SJ
J Physiol Pharmacol; 1997 Sep; 48(3):375-82. PubMed ID: 9376620
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of neurotensin on pentagastrin-stimulated gastric acid secretion in pylorus-ligated rats.
Hammer RA; Wagner B; Soyode HS
Biochem Biophys Res Commun; 1988 Apr; 152(1):231-6. PubMed ID: 3358763
[TBL] [Abstract][Full Text] [Related]
29. Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats.
Romano M; Lesch CA; Meise KS; Veljaca M; Sanchez B; Kraus ER; Boland CR; Guglietta A; Coffey RJ
Gastroenterology; 1996 May; 110(5):1448-55. PubMed ID: 8613050
[TBL] [Abstract][Full Text] [Related]
30. Effect of vasoactive intestinal peptide, peptide histidine isoleucine and growth hormone-releasing factor-40 on bombesin-like immunoreactivity, somatostatin and gastrin release from the perfused rat stomach.
Schusdziarra V; Schmid R; Bender H; Schusdziarra M; Rivier J; Vale W; Classen M
Peptides; 1986; 7(1):127-33. PubMed ID: 2872659
[TBL] [Abstract][Full Text] [Related]
31. Effect of PACAP on gastric acid secretion in rats.
Mungan Z; Hammer RA; Akarca US; Komaki G; Ertan A; Arimura A
Peptides; 1995; 16(6):1051-6. PubMed ID: 8532587
[TBL] [Abstract][Full Text] [Related]
32. Effect of epidermal growth factor on the development of rat gastric mucosa.
Dembinski AB; Johnson LR
Endocrinology; 1985 Jan; 116(1):90-4. PubMed ID: 2578037
[TBL] [Abstract][Full Text] [Related]
33. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters.
Snodgrass-Belt P; Gilbert JL; Davis FC
Brain Res; 2005 Mar; 1038(2):171-82. PubMed ID: 15757633
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor alpha inhibits secretion of gastric acid.
Rhodes JA; Tam JP; Finke U; Saunders M; Bernanke J; Silen W; Murphy RA
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3844-6. PubMed ID: 3487083
[TBL] [Abstract][Full Text] [Related]
35. Effects of transforming growth factor alpha and beta on rabbit gastric epithelial cell proliferation: a preliminary report.
Nakajima N; Kuwayama H
J Clin Gastroenterol; 1993; 17 Suppl 1():S121-4. PubMed ID: 8283006
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat.
Greeley GH; Guo YS; Gomez G; Lluis F; Singh P; Thompson JC
Proc Soc Exp Biol Med; 1988 Dec; 189(3):325-8. PubMed ID: 2905061
[TBL] [Abstract][Full Text] [Related]
37. Central neurotensin inhibits gastric acid secretion: an adrenergic mechanism in rats.
Zhang L; Xing LP; Demers L; Washington J; Kauffman GL
Gastroenterology; 1989 Nov; 97(5):1130-4. PubMed ID: 2551763
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2).
Li P; Chang TM; Coy D; Chey WY
Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G121-7. PubMed ID: 10644570
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
Bjellerup P; Theodorsson E; Kogner P
Eur J Cancer; 1995; 31A(4):481-5. PubMed ID: 7576950
[TBL] [Abstract][Full Text] [Related]
40. Heparin-binding EGF-like growth factor is an autocrine growth factor for rat gastric epithelial cells.
Miyazaki Y; Shinomura Y; Higashiyama S; Kanayama S; Higashimoto Y; Tsutsui S; Zushi S; Taniguchi N; Matsuzawa Y
Biochem Biophys Res Commun; 1996 Jun; 223(1):36-41. PubMed ID: 8660375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
